Kimberly Clark Corp (KMB) · Oct 15, 2026 · Earnings
No new info
Kimberly-Clark’s earnings filing announces preliminary Q3 data but supplies no sales, EPS, margin, or guidance figures to compare.
Kimberly-Clark is in the middle of a major portfolio transformation: shifting toward personal care and health-and-wellness categories while separating much of its tissue business into the Suzano joint venture and preparing to acquire Kenvue.
This filing does not provide the preliminary results it announces. The exhibit says Kimberly-Clark “today provided estimated preliminary financial data for the three months ended September 30, 2026,” but the supplied content contains no revenue, EPS, operating profit, margin, cash flow, or updated outlook figures.
There is therefore no beat, miss, or guidance read. Published Q3 expectations were approximately $1.62 in EPS and $4.158 billion in revenue, but the exhibit supplies neither result for comparison.
Bottom line: As provided, this is a notification rather than an earnings disclosure. It does not change the operating story until the full Q3 numbers and outlook are released.
Full Q3 earnings release and Q&A session
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!